MTP Session IV: Lymphoma 2    

Session Chair: Kieron Dunleavy, MD

• How Do We Fit Novel Agents Into the Management of Marginal Zone Lymphoma? | Narendranath Epperla, MD, MS | Huntsman Cancer Institute, Salt Lake City, Utah, USA

• Optimal Management of Waldenstrom’s Macroglobulinemia | Prashant Kapoor, MD | Mayo Clinic Rochester, Rochester, Minnesota, USA

• What Is Grey Zone Lymphoma and How Do We Treat It? | Kieron Dunleavy, MD | Lombardi Comprehensive Cancer Center, Washington, DC, USA